Gerd Wunderlich is currently doing research at TU Dresden. Wunderlich's main field of research is Thyrotropin receptor, while research in Trab and Radionuclide therapy have also been conducted. Jörg Kotzerke and Reinhard Brossmer have given noticeable influence on Wunderlich. Wunderlich has a record of over 20 years of research.
We use cookies to improve your online experience. By continuing to use our website we assume you agree to the placement of these cookies. To learn more, you can find in our Privacy Policy.